Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2003
09/25/2003US20030180848 PRO polypeptides; fusion proteins; immunoglobulins
09/25/2003US20030180847 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180845 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180844 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180843 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180842 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180841 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180840 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180839 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180838 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180837 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide
09/25/2003US20030180836 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180822 Detection of erythropoietin and erythropoietin receptor
09/25/2003US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma)
09/25/2003US20030180817 Determining levels of a colon specific gene in the cells, or bodily fluids in a patient, comparing determined levels of CSG with levels of CSG in cells from normal human control, wherein a change in level of CSG indicates presence of cancer
09/25/2003US20030180812 Novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
09/25/2003US20030180810 For diagnosis, prevention, and treatment of reproductive disorders, Alzheimer's disease, cancer, immunological disorders, and diabetes
09/25/2003US20030180799 Antibodies against plasma cells
09/25/2003US20030180796 Fibroblast/epidermal growth factors; PRO polypeptides
09/25/2003US20030180795 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides
09/25/2003US20030180794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180793 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides
09/25/2003US20030180792 Fusion proteins; PRO polypeptides; fibroblast/nerve growth factor receptors
09/25/2003US20030180791 Anti-proliferation domain of human Bcl-2 and DNA encoding the same
09/25/2003US20030180786 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180778 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
09/25/2003US20030180759 Antigen derived from the gp160 env precursor protein (glycoprotein120 envelop protein)of a HIV-1 group O strain contains an amino acid sequence characterized by the fact that it reacts with antibodies raised against such antigen
09/25/2003US20030180752 Type 2 cytokine receptor and nucleic acids encoding same
09/25/2003US20030180742 A polypetide; catalyzes the hydrolysis of epoxides and arene oxides to their corresponding diols
09/25/2003US20030180734 Peptide nucleic acids
09/25/2003US20030180722 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide
09/25/2003US20030180714 Shotgun scanning
09/25/2003US20030180706 Removal of prions from blood, plasma and other liquids
09/25/2003US20030180372 Water in oil emulsion; inoculating lymph nodes of pregnancy goat with virus
09/25/2003US20030180328 Forming vaccines; analyzing hemagglutinin, calibration
09/25/2003US20030180327 Veterinary medicine; induce immunology response
09/25/2003US20030180326 Methods and compositions for impairing multiplication of HIV-1
09/25/2003US20030180323 Diagnosis, prevention and treatment of calicivirus infection in humans
09/25/2003US20030180317 Diagnosis ear infections in children
09/25/2003US20030180315 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
09/25/2003US20030180311 Genetic engineering; binding to antibodies; drugs, medical diagnosis, biosensors
09/25/2003US20030180308 Deglycosylated ricin toxin a-chain vaccine
09/25/2003US20030180307 Polypeptides; detecting infections using antibodies
09/25/2003US20030180304 Enzyme inhibitor; tuberculosis therapy
09/25/2003US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation
09/25/2003US20030180299 Cardiovascular disorders
09/25/2003US20030180296 Antibodies that immunospecifically bind to trail receptors
09/25/2003US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
09/25/2003US20030180293 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
09/25/2003US20030180292 Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
09/25/2003US20030180290 Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies
09/25/2003US20030180286 Antiinflammatory agents; antitumor agents; vascular leakage; hypotensive agents; using nucleic acids
09/25/2003US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies
09/25/2003US20030180284 Monoclonal antibodies; vaccines
09/25/2003US20030180275 Human serpin polypeptides
09/25/2003US20030180266 Methods of expressing LIM mineralization protein in non-osseous cells
09/25/2003US20030180265 Modulating angiogenesis
09/25/2003US20030180252 Methods and compositions for enhancing immune response and for the production of in vitro Mabs
09/25/2003US20030180225 Walnut and ryegrass allergens
09/25/2003CA2799805A1 Optimizing glycan processing in plants
09/25/2003CA2479246A1 Method for overexpression of zwitterionic polysaccharides
09/25/2003CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003CA2478973A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
09/25/2003CA2478962A1 Cell surface tropomyosin as a target of angiogenesis inhibition
09/25/2003CA2478803A1 Methods of modulating cd200 receptors
09/25/2003CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/24/2003EP1347049A1 Novel potassium channel
09/24/2003EP1347048A1 Novel protease
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2)
09/24/2003EP1346056A1 Methods for the production of multimeric proteins, and related compositions
09/24/2003EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
09/24/2003EP1346053A2 Polynucleotides encoding human phosphatases
09/24/2003EP1346052A2 Histone deacetylase-related gene and protein
09/24/2003EP1346051A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/24/2003EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same
09/24/2003EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
09/24/2003EP1346034A2 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346032A2 Method for the production of carbohydrates
09/24/2003EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
09/24/2003EP1346029A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
09/24/2003EP1345969A2 Anti-cd28 antibody
09/24/2003EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/24/2003EP1345967A2 Phage display libraries of human v h fragments
09/24/2003EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
09/24/2003EP1345964A2 Polypeptides having a triggering nk activity and biological applications
09/24/2003EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
09/24/2003EP1345960A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau-r4
09/24/2003EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
09/24/2003EP1345623A2 Immunogenic proteoliposomes, and uses thereof
09/24/2003EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies
09/24/2003EP1345495A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics
09/24/2003EP0985032B1 Ribosome complexes as selection particles for in vitro display and evolution of proteins
09/24/2003EP0909388B1 Immunological assay for spongiform encephalopathies
09/24/2003EP0856066B1 Method for determining activity of dna polymerases
09/24/2003EP0764048B1 Chromatography adsorbents utilizing mercapto heterocyclic ligands
09/24/2003EP0535216B1 Dna encoding mammalian phosphodiesterases